FDA denies approval to wider use of J&J's blood clot preventer

[riky]

FDA denies approval to wider use of J&J's blood clot preventer

(Reuters) - The U.S. Food and Drug Administration denied an approval to a wider use of Johnson & Johnson's heart drug Xarelto. J&J's unit Janssen Research & Development was seeking approval for using the drug to reduce the risk of heart problems, such as heart attack, stroke or death, in patients with acute coronary syndrome and to reduce the risk of stent thrombosis - a blood clot at the site of the stent.

Source: You are not allowed to view links. Register or Login